Actively Recruiting
Contrast-Enhanced Photon-Counting Detector CT (PCD-CT) for the Local Staging of Rectal Cancer
Led by Mayo Clinic · Updated on 2026-04-22
200
Participants Needed
1
Research Sites
116 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
This study evaluates whether images taken using a photon counting detector CT scanner (PCD-CT) can determine the growth of rectal cancer as well as, or better than, MRI for the management of patients with rectal cancer.
CONDITIONS
Official Title
Contrast-Enhanced Photon-Counting Detector CT (PCD-CT) for the Local Staging of Rectal Cancer
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Adult patients 18 to 99 years of age
- Proven rectal cancer and clinically referred for staging pelvic MRI and contrast-enhanced CT of the abdomen and pelvis
- Tumor size of 2 cm or larger based on endoscopic or imaging reports
- Ability and willingness to sign informed consent
- Negative pregnancy test for females of child-bearing potential
You will not qualify if you...
- Under 18 years old
- Unable to provide written informed consent
- Pregnancy
- Estimated Glomerular Filtration Rate (eGFR) of 60 or less
- History of moderate or severe allergic reaction to contrast including serious symptoms
- History of premedication before iodinated contrast
- Bilateral hip replacement or prosthesis
- Patients who consent but do not undergo their required MRI scan for any reason
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Mayo Clinic in Rochester
Rochester, Minnesota, United States, 55905
Actively Recruiting
Research Team
C
Clinical Trials Referral Office
CONTACT
B
Boleyn Andrist
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here